Author

MD Spencer Behr

Observed names: MD Spencer Behr,, Spencer Behr

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Observed institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

OpenAlex ID: A5064101313

Counterfactuals and uncertainty-based explainable paradigm for the automated detection and segmentation of renal cysts in contrast-enhanced abdominal computed tomography: A multi-center study

2026 · Zohaib Salahuddin, Sheng Kuang, et al. · Artificial Intelligence in Medicine

Efficacy and safety of cabozantinib (CABO) in advanced neuroendocrine tumors (NET) according to hormone functional status: Subgroup analysis of phase 3 CABINET trial (Alliance A021602).

2026 · Nikolaos Trikalinos, Susan Michelle Geyer, et al. · Journal of Clinical Oncology

Updated results of CABINET trial/alliance A021602: cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy

2025 · MD Thorvardur R. Halfdanarson,, PhD Susan Geyer,, et al. · Endocrine Abstracts

Works count: 3

Citation count:

H-index:

I10-index: